Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GM-CSF”

484 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 484 results

Testing effectiveness (Phase 2)Study completedNCT01265368
What this trial is testing

A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET)

Who this might be right for
Stage IV Renal Cell Cancer
Mologen AG 19
Testing effectiveness (Phase 2)Study completedNCT01334515
What this trial is testing

Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma

Who this might be right for
Recurrent Neuroblastoma
Children's Oncology Group 52
Large-scale testing (Phase 3)UnknownNCT00091676
What this trial is testing

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Biovest International 629
Testing effectiveness (Phase 2)Ended earlyNCT00329537
What this trial is testing

Study of Sargramostim in Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Genzyme, a Sanofi Company 11
Testing effectiveness (Phase 2)Study completedNCT00004256
What this trial is testing

Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT01222221
What this trial is testing

Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 45
Early research (Phase 1)Study completedNCT00383994
What this trial is testing

Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation

Who this might be right for
LymphomaLeukemiaTransplantation, Stem Cell+2 more
M.D. Anderson Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT00002070
What this trial is testing

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Schering-Plough
Testing effectiveness (Phase 2)Study completedNCT00101101
What this trial is testing

Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma

Who this might be right for
Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 43
Testing effectiveness (Phase 2)Study completedNCT00901511
What this trial is testing

Inhaled GM-CSF Therapy of Autoimmune PAP

Who this might be right for
Autoimmune Pulmonary Alveolar Proteinosis
Fondazione IRCCS Policlinico San Matteo di Pavia 18
Testing effectiveness (Phase 2)WithdrawnNCT00022230
What this trial is testing

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00208975
What this trial is testing

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab

Who this might be right for
Lymphoma
Emory University 15
Large-scale testing (Phase 3)Study completedNCT02361528
What this trial is testing

GM-CSF to Decrease ICU Acquired Infections

Who this might be right for
Septic ShockSevere Sepsis
Hospices Civils de Lyon 166
Testing effectiveness (Phase 2)Study completedNCT00501644
What this trial is testing

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)UnknownNCT04979832
What this trial is testing

GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery

Who this might be right for
Pouchitis
Zealand University Hospital 18
Early research (Phase 1)Study completedNCT00257738
What this trial is testing

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Maryland, Baltimore 17
Testing effectiveness (Phase 2)Ended earlyNCT00002778
What this trial is testing

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Testing effectiveness (Phase 2)Study completedNCT04351243
What this trial is testing

Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

Who this might be right for
COVID-19
Kinevant Sciences GmbH 227
Early research (Phase 1)Study completedNCT00002006
What this trial is testing

A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Next Page